tiprankstipranks
Trending News
More News >
Covalon Technologies Ltd (TSE:COV)
:COV
Canadian Market

Covalon Technologies (COV) Price & Analysis

Compare
29 Followers

COV Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

14.34%85.66%
14.34% Insiders
Mutual Funds
― Other Institutional Investors
85.66% Public Companies and
Individual Investors

COV FAQ

What was Covalon Technologies Ltd’s price range in the past 12 months?
Covalon Technologies Ltd lowest stock price was C$2.01 and its highest was C$4.30 in the past 12 months.
    What is Covalon Technologies Ltd’s market cap?
    Covalon Technologies Ltd’s market cap is C$71.29M.
      When is Covalon Technologies Ltd’s upcoming earnings report date?
      Covalon Technologies Ltd’s upcoming earnings report date is Sep 01, 2025 which is in 57 days.
        How were Covalon Technologies Ltd’s earnings last quarter?
        Covalon Technologies Ltd released its earnings results on May 28, 2025. The company reported C$0.02 earnings per share for the quarter, beating the consensus estimate of C$0.01 by C$0.01.
          Is Covalon Technologies Ltd overvalued?
          According to Wall Street analysts Covalon Technologies Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Covalon Technologies Ltd pay dividends?
            Covalon Technologies Ltd does not currently pay dividends.
            What is Covalon Technologies Ltd’s EPS estimate?
            Covalon Technologies Ltd’s EPS estimate is 0.04.
              How many shares outstanding does Covalon Technologies Ltd have?
              Covalon Technologies Ltd has 27,418,077 shares outstanding.
                What happened to Covalon Technologies Ltd’s price movement after its last earnings report?
                Covalon Technologies Ltd reported an EPS of C$0.02 in its last earnings report, beating expectations of C$0.01. Following the earnings report the stock price went down -8.214%.
                  Which hedge fund is a major shareholder of Covalon Technologies Ltd?
                  Currently, no hedge funds are holding shares in TSE:COV

                  Covalon Technologies Stock Smart Score

                  2
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  23.80%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  14.51%
                  Trailing 12-Months
                  Asset Growth
                  50.92%
                  Trailing 12-Months

                  Company Description

                  Covalon Technologies Ltd

                  Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. Its products include wound care dressings; surgical and peri-operative products; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Oncolytics Biotech
                  Helix BioPharma
                  Microbix Biosystms
                  Medmira
                  Sernova
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis